output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. *Glaucoma Drainage Implants [adverse effects]; 2. *Intraocular Pressure; 3. Cataract Extraction; 4. Glaucoma [*surgery]; 5. Molteno Implants [adverse effects]; 6. Ocular Hypertension [surgery]; 7. Randomized Controlled Trials as Topic; 8. Trabeculectomy; | Provide MESH terms for the study
Aqueous shunts for glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Age Factors; 2. Anti‐Bacterial Agents [therapeutic use]; 3. Cost‐Benefit Analysis; 4. Dacryocystorhinostomy [adverse effects, economics, instrumentation, *methods]; 5. Lacrimal Duct Obstruction [*congenital, *therapy]; 6. Massage; 7. Randomized Controlled Trials as Topic; 8. Remission, Spontaneous; 9. Reoperation [statistics & numerical data]; 10. Surgical Instruments; 11. Time Factors; 12. Watchful Waiting; | Provide MESH terms for the study
Probing for congenital nasolacrimal duct obstruction | You are a research assistant. Based on the question please provide appropriate answers |
1. *Phacoemulsification [adverse effects]; 2. Adrenal Cortex Hormones [*therapeutic use]; 3. Anti‐Inflammatory Agents, Non‐Steroidal [*therapeutic use]; 4. Cataract Extraction [*adverse effects, *methods]; 5. Corneal Edema [etiology, prevention & control]; 6. Drug Therapy, Combination; 7. Eye Diseases [etiology, *prevention & control]; 8. Inflammation [etiology, prevention & control]; 9. Macular Edema [etiology, prevention & control]; 10. Postoperative Complications [etiology, *prevention & control]; 11. Randomized Controlled Trials as Topic; 12. Visual Acuity; | Provide MESH terms for the study
Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Eye Diseases [*surgery]; 2. Lasers, Solid‐State [*therapeutic use]; 3. Vitrectomy [*methods]; | Provide MESH terms for the study
Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Anti‐Inflammatory Agents, Non‐Steroidal [*administration & dosage, adverse effects]; 3. Corneal Injuries [complications, *drug therapy]; 4. Diclofenac [administration & dosage]; 5. Flurbiprofen [administration & dosage]; 6. Indomethacin [administration & dosage]; 7. Ketorolac [administration & dosage]; 8. Pain Measurement; 9. Randomized Controlled Trials as Topic; 10. Wound Healing; | Provide MESH terms for the study
Topical non‐steroidal anti‐inflammatory drugs for analgesia in traumatic corneal abrasions | You are a research assistant. Based on the question please provide appropriate answers |
1. *Serum; 2. Dry Eye Syndromes [*therapy]; 3. Lubricant Eye Drops [*administration & dosage]; 4. Ophthalmic Solutions [therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Sodium Chloride [therapeutic use]; 7. Tears [physiology]; | Provide MESH terms for the study
Autologous serum eye drops for dry eye | You are a research assistant. Based on the question please provide appropriate answers |
1. Aging; 2. Carnosine [administration & dosage, *analogs & derivatives]; 3. Cataract [*drug therapy, etiology]; 4. Disease Progression; 5. Ophthalmic Solutions [administration & dosage]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
N‐acetylcarnosine (NAC) drops for age‐related cataract | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Loss, Surgical; 2. Dacryocystorhinostomy [adverse effects, *methods]; 3. Laser Therapy [methods]; 4. Postoperative Hemorrhage [etiology]; 5. Randomized Controlled Trials as Topic; 6. Surgical Wound Infection [etiology]; 7. Treatment Failure; | Provide MESH terms for the study
Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic alpha‐2 Receptor Agonists [therapeutic use]; 2. Antihypertensive Agents [adverse effects, *therapeutic use]; 3. Brimonidine Tartrate [therapeutic use]; 4. Clonidine [analogs & derivatives, therapeutic use]; 5. Conjunctiva [drug effects]; 6. Glaucoma, Open‐Angle [*surgery]; 7. Intraocular Pressure [*drug effects]; 8. Ocular Hypertension [*prevention & control]; 9. Pilocarpine [therapeutic use]; 10. Postoperative Complications [*prevention & control]; 11. Randomized Controlled Trials as Topic; 12. Trabeculectomy [*adverse effects]; | Provide MESH terms for the study
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Ophthalmic; 2. Antihypertensive Agents [*administration & dosage, adverse effects]; 3. Bimatoprost [administration & dosage]; 4. Eyelashes [anatomy & histology, drug effects]; 5. Glaucoma [*drug therapy]; 6. Intraocular Pressure [*drug effects]; 7. Latanoprost; 8. Ophthalmic Solutions [administration & dosage, adverse effects]; 9. Prostaglandins F, Synthetic [administration & dosage]; 10. Randomized Controlled Trials as Topic; 11. Travoprost [administration & dosage]; | Provide MESH terms for the study
Topical medication instillation techniques for glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Cataract [*complications]; 2. Cataract Extraction [*adverse effects]; 3. Disease Progression; 4. Macular Degeneration [*complications, pathology]; 5. Randomized Controlled Trials as Topic; 6. Time Factors; 7. Visual Acuity; | Provide MESH terms for the study
Surgery for cataracts in people with age‐related macular degeneration | You are a research assistant. Based on the question please provide appropriate answers |
1. Keratectomy, Subepithelial, Laser‐Assisted [adverse effects, *methods]; 2. Keratomileusis, Laser In Situ [adverse effects, *methods]; 3. Myopia [*surgery]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Visual Acuity; | Provide MESH terms for the study
Laser‐assisted subepithelial keratectomy (LASEK) versus laser‐assisted in‐situ keratomileusis (LASIK) for correcting myopia | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Anti‐Bacterial Agents [*administration & dosage]; 3. Cataract Extraction [*adverse effects]; 4. Endophthalmitis [*prevention & control]; 5. Injections, Intraocular [methods]; 6. Ophthalmic Solutions [administration & dosage]; 7. Postoperative Complications [*prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Therapeutic Irrigation [methods]; 10. Visual Acuity; | Provide MESH terms for the study
Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Hordeolum [pathology, *therapy]; | Provide MESH terms for the study
Non‐surgical interventions for acute internal hordeolum | You are a research assistant. Based on the question please provide appropriate answers |
1. *Laser Coagulation; 2. *Photochemotherapy; 3. Angiogenesis Inhibitors [adverse effects, *therapeutic use]; 4. Bevacizumab [therapeutic use]; 5. Choroidal Neovascularization [etiology, *therapy]; 6. Macula Lutea [surgery]; 7. Myopia, Degenerative [*complications]; 8. Photosensitizing Agents [therapeutic use]; 9. Porphyrins [therapeutic use]; 10. Randomized Controlled Trials as Topic; 11. Ranibizumab [therapeutic use]; 12. Receptors, Vascular Endothelial Growth Factor [therapeutic use]; 13. Recombinant Fusion Proteins [therapeutic use]; 14. Vascular Endothelial Growth Factor A [*antagonists & inhibitors]; 15. Verteporfin; | Provide MESH terms for the study
Anti‐vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Lenses, Intraocular [psychology]; 2. Cataract Extraction [*rehabilitation]; 3. Contrast Sensitivity [physiology]; 4. Patient Satisfaction; 5. Prosthesis Design; 6. Randomized Controlled Trials as Topic; 7. Vision, Ocular [physiology]; 8. Visual Acuity [*physiology]; | Provide MESH terms for the study
Multifocal versus monofocal intraocular lenses after cataract extraction | You are a research assistant. Based on the question please provide appropriate answers |
1. *Autografts; 2. *Sutures; 3. Conjunctiva [*transplantation]; 4. Fibrin Tissue Adhesive [adverse effects, *therapeutic use]; 5. Pterygium [prevention & control, *surgery]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Secondary Prevention [*methods]; 9. Tissue Adhesives [adverse effects, *therapeutic use]; 10. Transplantation, Autologous; | Provide MESH terms for the study
Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Corneal Transplantation; 2. Acyclovir [*administration & dosage]; 3. Administration, Oral; 4. Antiviral Agents [*administration & dosage]; 5. Keratitis, Herpetic [*prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Secondary Prevention [*methods]; 9. Time Factors; | Provide MESH terms for the study
Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts | You are a research assistant. Based on the question please provide appropriate answers |
1. *Immunocompetence; 2. Acyclovir [adverse effects, *analogs & derivatives, *therapeutic use]; 3. Antiviral Agents [adverse effects, *therapeutic use]; 4. Herpes Zoster Ophthalmicus [*drug therapy, immunology]; 5. Randomized Controlled Trials as Topic; 6. Valacyclovir; 7. Valine [adverse effects, *analogs & derivatives, therapeutic use]; | Provide MESH terms for the study
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Anophthalmos [etiology, *rehabilitation]; 2. *Durapatite; 3. Eye Enucleation [*rehabilitation]; 4. Eye Evisceration [*rehabilitation]; 5. *Orbital Implants [classification]; 6. *Polyethylene; 7. *Polymethyl Methacrylate; 8. Prosthesis Design; 9. Prosthesis Implantation [*methods]; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Integrated versus non‐integrated orbital implants for treating anophthalmic sockets | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Anti‐Inflammatory Agents, Non‐Steroidal [adverse effects, *therapeutic use]; 3. Cataract Extraction [*adverse effects]; 4. Macular Edema [etiology, *prevention & control]; 5. Postoperative Complications [*prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Steroids [therapeutic use]; | Provide MESH terms for the study
Prophylactic non‐steroidal anti‐inflammatory drugs for the prevention of macular oedema after cataract surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Hydroxymethylglutaryl‐CoA Reductase Inhibitors [adverse effects, *therapeutic use]; 2. Macular Degeneration [*prevention & control]; 3. Randomized Controlled Trials as Topic; 4. Simvastatin [adverse effects, *therapeutic use]; 5. Visual Acuity; | Provide MESH terms for the study
Statins for age‐related macular degeneration | You are a research assistant. Based on the question please provide appropriate answers |
1. *Occlusive Dressings [adverse effects]; 2. Analgesics [therapeutic use]; 3. Corneal Injuries [*therapy]; 4. Eye Foreign Bodies [complications]; 5. Pain Measurement; 6. Randomized Controlled Trials as Topic; 7. Time Factors; 8. Wound Healing; | Provide MESH terms for the study
Patching for corneal abrasion | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Anti‐Bacterial Agents [administration & dosage, *therapeutic use]; 3. Chorioretinitis [*drug therapy, parasitology]; 4. Drug Combinations; 5. Pyrimethamine [therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Secondary Prevention; 9. Sulfadiazine [therapeutic use]; 10. Sulfamerazine [therapeutic use]; 11. Sulfamethazine [therapeutic use]; 12. Toxoplasmosis, Ocular [complications, *drug therapy]; 13. Trimethoprim, Sulfamethoxazole Drug Combination [administration & dosage, therapeutic use]; 14. Visual Acuity; 15. Watchful Waiting; | Provide MESH terms for the study
Antibiotics versus no treatment for toxoplasma retinochoroiditis | You are a research assistant. Based on the question please provide appropriate answers |
1. Acrylic Resins [administration & dosage]; 2. Dry Eye Syndromes [*drug therapy]; 3. Lubricant Eye Drops [*administration & dosage, chemistry]; 4. Nonprescription Drugs [administration & dosage, chemistry]; 5. Polyvinyl Alcohol [administration & dosage]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Over the counter (OTC) artificial tear drops for dry eye syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. *Keratectomy, Subepithelial, Laser‐Assisted [adverse effects]; 2. *Photorefractive Keratectomy [adverse effects]; 3. Myopia [*surgery]; 4. Randomized Controlled Trials as Topic; 5. Time Factors; 6. Visual Acuity; | Provide MESH terms for the study
Laser‐assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia | You are a research assistant. Based on the question please provide appropriate answers |
1. Aluminum [therapeutic use]; 2. Antihypertensive Agents [therapeutic use]; 3. Glaucoma, Open-Angle [drug therapy, *surgery]; 4. Intraocular Pressure; 5. Iris [*surgery]; 6. Laser Therapy [adverse effects, *methods]; 7. Ophthalmologic Surgical Procedures; 8. Randomized Controlled Trials as Topic; 9. Visual Acuity; 10. Yttrium [therapeutic use]; | Provide MESH terms for the study
Peripheral iridotomy for pigmentary glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Autografts; 2. Amnion [transplantation]; 3. Conjunctiva [*transplantation]; 4. Pterygium [*surgery]; 5. Randomized Controlled Trials as Topic; 6. Recurrence; 7. Time Factors; | Provide MESH terms for the study
Conjunctival autograft for pterygium | You are a research assistant. Based on the question please provide appropriate answers |
1. Angiogenesis Inhibitors [*therapeutic use]; 2. Choroidal Neovascularization [complications, *drug therapy]; 3. Macular Degeneration [*drug therapy, etiology]; 4. Ranibizumab [therapeutic use]; 5. Receptors, Vascular Endothelial Growth Factor [*therapeutic use]; 6. Recombinant Fusion Proteins [*therapeutic use]; 7. Visual Acuity; | Provide MESH terms for the study
Aflibercept for neovascular age‐related macular degeneration | You are a research assistant. Based on the question please provide appropriate answers |
1. Doxycycline [adverse effects, *therapeutic use]; 2. Drug Therapy, Combination; 3. Filaricides [adverse effects, *therapeutic use]; 4. Ivermectin [adverse effects, *therapeutic use]; 5. Onchocerciasis [*drug therapy, prevention & control]; 6. Onchocerciasis, Ocular [drug therapy, prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Vision Disorders [prevention & control]; | Provide MESH terms for the study
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis | You are a research assistant. Based on the question please provide appropriate answers |
1. Angiogenesis Inhibitors [*therapeutic use]; 2. Bevacizumab [therapeutic use]; 3. Cicatrix [prevention & control]; 4. Glaucoma [*surgery]; 5. Intraocular Pressure; 6. Mitomycin [therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Ranibizumab [therapeutic use]; 9. Trabeculectomy [adverse effects]; 10. Vascular Endothelial Growth Factor A [*antagonists & inhibitors]; 11. Wound Healing [*drug effects]; | Provide MESH terms for the study
Anti‐vascular endothelial growth factor for control of wound healing in glaucoma surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Oculomotor Muscles [*surgery]; 2. Randomized Controlled Trials as Topic; 3. Strabismus [*surgery]; 4. Treatment Outcome; | Provide MESH terms for the study
Interventions for dissociated vertical deviation | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [therapeutic use]; 2. Chlamydia trachomatis; 3. Entropion [etiology, *surgery]; 4. Eyelid Diseases [surgery, *therapy]; 5. Hair Removal [methods]; 6. Randomized Controlled Trials as Topic; 7. Trachoma [surgery, *therapy]; | Provide MESH terms for the study
Interventions for trachoma trichiasis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Trabeculectomy; 2. Antimetabolites [*therapeutic use]; 3. Chemotherapy, Adjuvant; 4. Cicatrix [prevention & control]; 5. Fluorouracil [*therapeutic use]; 6. Glaucoma [drug therapy, *surgery]; 7. Intraocular Pressure [drug effects]; 8. Mitomycin [*therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Risk; 11. Treatment Failure; 12. Wound Healing [*drug effects]; | Provide MESH terms for the study
Mitomycin C versus 5‐Fluorouracil for wound healing in glaucoma surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Ambulatory Surgical Procedures [economics, methods]; 2. *Cataract Extraction [economics, methods]; 3. *Hospitalization [economics]; 4. Feasibility Studies; 5. Postoperative Complications; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Visual Acuity; | Provide MESH terms for the study
Day care versus in‐patient surgery for age‐related cataract | You are a research assistant. Based on the question please provide appropriate answers |
1. Disease Progression; 2. Geographic Atrophy [prevention & control]; 3. Laser Coagulation [methods]; 4. Macular Degeneration [*prevention & control]; 5. Randomized Controlled Trials as Topic; 6. Retinal Drusen [complications, *surgery]; 7. Visual Acuity; | Provide MESH terms for the study
Laser treatment of drusen to prevent progression to advanced age‐related macular degeneration | You are a research assistant. Based on the question please provide appropriate answers |
1. Dexamethasone [administration & dosage]; 2. Intravitreal Injections; 3. Macular Edema [*drug therapy, etiology]; 4. Randomized Controlled Trials as Topic; 5. Retinal Vein Occlusion [*complications]; 6. Steroids [*administration & dosage]; 7. Triamcinolone [administration & dosage]; 8. Visual Acuity; 9. Watchful Waiting; | Provide MESH terms for the study
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract Extraction; 2. Anesthesia, Local [adverse effects, *methods]; 3. Anesthetics, Local [*administration & dosage]; 4. Nerve Block [*methods]; 5. Pain [etiology]; 6. Pain Measurement; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Sub‐Tenon's anaesthesia versus topical anaesthesia for cataract surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Keratoplasty, Penetrating; 2. Cyclosporine [therapeutic use]; 3. Graft Rejection [*drug therapy]; 4. Graft Survival; 5. Immunosuppressive Agents [*therapeutic use]; 6. Mycophenolic Acid [analogs & derivatives, therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Steroids [therapeutic use]; 9. Tacrolimus [therapeutic use]; | Provide MESH terms for the study
Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Administration, Oral; 3. Anti-Inflammatory Agents [administration & dosage, *therapeutic use]; 4. Contrast Sensitivity [drug effects]; 5. Dexamethasone [administration & dosage, therapeutic use]; 6. Glucocorticoids [administration & dosage, *therapeutic use]; 7. Injections, Intravenous; 8. Methylprednisolone [administration & dosage, therapeutic use]; 9. Optic Neuritis [*drug therapy]; 10. Prednisone [administration & dosage, therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Visual Acuity [drug effects]; | Provide MESH terms for the study
Corticosteroids for treating optic neuritis | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetazolamide [*therapeutic use]; 2. Antihypertensive Agents [*therapeutic use]; 3. Cerebrospinal Fluid Pressure [drug effects]; 4. Headache [drug therapy]; 5. Intracranial Hypertension [*therapy]; 6. Randomized Controlled Trials as Topic; 7. Visual Acuity; 8. Weight Loss; | Provide MESH terms for the study
Interventions for idiopathic intracranial hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Cataract [*complications]; 2. Combined Modality Therapy [methods]; 3. Glaucoma [*complications, *surgery]; 4. Intraocular Pressure; 5. Phacoemulsification [adverse effects, *methods]; 6. Randomized Controlled Trials as Topic; 7. Stents; 8. Trabecular Meshwork [surgery]; 9. Trabeculectomy [adverse effects, *methods]; 10. Treatment Outcome; | Provide MESH terms for the study
Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Self‐Help Devices; 2. Vision, Low [*rehabilitation]; | Provide MESH terms for the study
Assistive technology for children and young people with low vision | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Inflammatory Agents [therapeutic use]; 2. Antibodies, Monoclonal, Humanized [administration & dosage]; 3. Bevacizumab; 4. Laser Coagulation [adverse effects, *methods]; 5. Macular Edema [etiology, *surgery]; 6. Randomized Controlled Trials as Topic; 7. Retinal Vein Occlusion [*complications]; 8. Triamcinolone [administration & dosage]; 9. Visual Acuity [drug effects]; | Provide MESH terms for the study
Macular grid laser photocoagulation for branch retinal vein occlusion | You are a research assistant. Based on the question please provide appropriate answers |
1. Antifungal Agents [*therapeutic use]; 2. Eye Infections, Fungal [*drug therapy]; 3. Keratitis [*drug therapy, microbiology]; 4. Natamycin [therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Voriconazole [therapeutic use]; | Provide MESH terms for the study
Medical interventions for fungal keratitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Early Termination of Clinical Trials; 2. Optic Neuropathy, Ischemic [*surgery]; 3. Postoperative Complications; 4. Randomized Controlled Trials as Topic; 5. Treatment Failure; 6. Visual Acuity; | Provide MESH terms for the study
Surgery for nonarteritic anterior ischemic optic neuropathy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Reading; 2. Optical Devices; 3. Vision, Low [*rehabilitation]; | Provide MESH terms for the study
Optical reading aids for children and young people with low vision | You are a research assistant. Based on the question please provide appropriate answers |
1. Acanthamoeba Keratitis [*drug therapy]; 2. Anti‐Infective Agents, Local [*therapeutic use]; 3. Biguanides [*therapeutic use]; 4. Chlorhexidine [*therapeutic use]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Medical interventions for acanthamoeba keratitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Face; 2. Anti‐Bacterial Agents [administration & dosage]; 3. Australia; 4. Baths [*methods]; 5. Chlamydia trachomatis; 6. Combined Modality Therapy [methods]; 7. Ophthalmic Solutions [therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Skin Care [*methods]; 10. Tanzania; 11. Tetracycline [administration & dosage]; 12. Trachoma [epidemiology, *prevention & control]; | Provide MESH terms for the study
Face washing promotion for preventing active trachoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Administration, Topical; 3. Antiviral Agents [*administration & dosage]; 4. Combined Modality Therapy [methods]; 5. Debridement [*methods]; 6. Interferons [administration & dosage]; 7. Keratitis, Herpetic [*therapy]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Retinal Degeneration [*therapy]; 2. Retinal Detachment [*prevention & control]; 3. Retinal Perforations [*therapy]; | Provide MESH terms for the study
Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment | You are a research assistant. Based on the question please provide appropriate answers |
1. *Phakic Intraocular Lenses [adverse effects]; 2. Astigmatism [surgery]; 3. Cataract [etiology]; 4. Lasers, Excimer [adverse effects, *therapeutic use]; 5. Myopia [*surgery]; 6. Randomized Controlled Trials as Topic; 7. Visual Acuity; | Provide MESH terms for the study
Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia | You are a research assistant. Based on the question please provide appropriate answers |
1. Chelating Agents [*therapeutic use]; 2. Infant, Premature; 3. Penicillamine [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Retinopathy of Prematurity [*prevention & control]; | Provide MESH terms for the study
D‐Penicillamine for preventing retinopathy of prematurity in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Colitis, Ulcerative [drug therapy]; 2. *Crohn Disease [drug therapy]; 3. Neoplasm Recurrence, Local; 4. Recurrence; 5. Remission Induction; 6. Vitamin D [adverse effects]; | Provide MESH terms for the study
Vitamin D for the treatment of inflammatory bowel disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Loss, Surgical [prevention & control]; 2. *Fibrin [therapeutic use]; 3. *Hemostatics [therapeutic use]; 4. Liver; 5. Quality of Life; | Provide MESH terms for the study
Fibrin‐based haemostatic agents for reducing blood loss in adult liver resection | You are a research assistant. Based on the question please provide appropriate answers |
1. Liver; 2. *Prostaglandins [therapeutic use]; 3. *Quality of Life; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Prostaglandins for adult liver transplanted recipients | You are a research assistant. Based on the question please provide appropriate answers |
1. Ascites [etiology, therapy]; 2. Gastrointestinal Hemorrhage [etiology]; 3. *Hepatic Encephalopathy [etiology]; 4. Liver Cirrhosis [complications]; 5. Polytetrafluoroethylene [adverse effects]; 6. *Portasystemic Shunt, Transjugular Intrahepatic [adverse effects, methods]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Stents [adverse effects]; | Provide MESH terms for the study
Expanded polytetrafluoroethylene (ePTFE)‐covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Ammonia; 2. Disaccharides [adverse effects]; 3. *Hepatic Encephalopathy [drug therapy, prevention & control]; 4. Liver Cirrhosis [complications]; 5. Quality of Life; 6. Rifaximin [therapeutic use]; | Provide MESH terms for the study
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Fibrin Tissue Adhesive [therapeutic use]; 2. Pancreas [surgery]; 3. Pancreatectomy [adverse effects, methods]; 4. *Pancreatic Fistula [etiology, prevention & control]; 5. Pancreaticoduodenectomy; 6. Postoperative Complications; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Acute-On-Chronic Liver Failure [complications]; 2. *Erythropoietin; 3. *Esophageal and Gastric Varices [complications]; 4. Gastrointestinal Hemorrhage; 5. Granulocyte Colony-Stimulating Factor [therapeutic use]; 6. Growth Hormone; 7. Intercellular Signaling Peptides and Proteins; 8. Liver Cirrhosis [complications]; 9. Quality of Life; 10. Stem Cells; | Provide MESH terms for the study
Granulocyte colony‐stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cardiovascular Diseases [prevention & control]; 2. Exercise Therapy [adverse effects]; 3. Fatigue [etiology]; 4. *Liver Transplantation [adverse effects]; 5. *Metabolic Syndrome [complications]; 6. Quality of Life; | Provide MESH terms for the study
Exercise interventions for adults after liver transplantation | You are a research assistant. Based on the question please provide appropriate answers |
1. Chronic Disease; 2. *Colitis, Ulcerative; 3. *COVID-19; 4. *Crohn Disease [therapy]; 5. Neoplasm Recurrence, Local; 6. Quality of Life; 7. *Telemedicine; | Provide MESH terms for the study
Remote care through telehealth for people with inflammatory bowel disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Chronic Disease; 2. *Colitis, Ulcerative [therapy]; 3. *Crohn Disease; 4. *Inflammatory Bowel Diseases [therapy]; 5. Neoplasm Recurrence, Local; 6. Patient Education as Topic; 7. Quality of Life; | Provide MESH terms for the study
Patient education interventions for the management of inflammatory bowel disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Endoscopy; 2. *Erythromycin [adverse effects]; 3. Gastrointestinal Hemorrhage [drug therapy]; 4. *Metoclopramide; 5. Treatment Outcome; | Provide MESH terms for the study
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage | You are a research assistant. Based on the question please provide appropriate answers |
1. China; 2. Controlled Before-After Studies; 3. Diarrhea [epidemiology, prevention & control]; 4. *Dysentery; 5. Non-Randomized Controlled Trials as Topic; 6. Randomized Controlled Trials as Topic; 7. *Sanitation; | Provide MESH terms for the study
Interventions to improve sanitation for preventing diarrhoea | You are a research assistant. Based on the question please provide appropriate answers |
1. *Esophageal Achalasia [surgery]; 2. *Heller Myotomy; 3. *Margins of Excision; | Provide MESH terms for the study
Fundoplication in laparoscopic Heller's cardiomyotomy for achalasia | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [therapeutic use]; 2. *Anti-Infective Agents [therapeutic use]; 3. Azithromycin [adverse effects]; 4. Cefixime [therapeutic use]; 5. Ceftriaxone [therapeutic use]; 6. Cephalosporins [therapeutic use]; 7. Chloramphenicol [therapeutic use]; 8. Ciprofloxacin [therapeutic use]; 9. Fluoroquinolones [therapeutic use]; 10. Monobactams [therapeutic use]; 11. Ofloxacin [therapeutic use]; 12. Pakistan; 13. *Paratyphoid Fever [drug therapy]; 14. Recurrence; 15. *Typhoid Fever [drug therapy]; | Provide MESH terms for the study
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins | You are a research assistant. Based on the question please provide appropriate answers |
1. Cross-Sectional Studies; 2. Electromagnetic Phenomena; 3. *Endoscopy; 4. *Pneumonia; 5. Retrospective Studies; | Provide MESH terms for the study
Electromagnetic‐guided versus endoscopic‐guided postpyloric placement of nasoenteral feeding tubes | You are a research assistant. Based on the question please provide appropriate answers |
1. *Certolizumab Pegol [adverse effects]; 2. *Crohn Disease [drug therapy]; 3. Inflammation; 4. Randomized Controlled Trials as Topic; 5. Recurrence; 6. Remission Induction; | Provide MESH terms for the study
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Abdominal Pain; 2. Exercise; 3. *Irritable Bowel Syndrome [therapy]; 4. Quality of Life; 5. *Yoga; | Provide MESH terms for the study
Physical activity for treatment of irritable bowel syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. *Anti-Bacterial Agents [therapeutic use]; 2. Colon; 3. *Diverticulitis [drug therapy]; 4. Length of Stay; | Provide MESH terms for the study
Antibiotics for uncomplicated diverticulitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Constriction, Pathologic; 2. *Crohn Disease [drug therapy]; 3. *Hematopoietic Stem Cell Transplantation; 4. Inflammation; 5. Remission Induction; | Provide MESH terms for the study
Stem cell transplantation for induction of remission in medically refractory Crohn’s disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [therapeutic use]; 2. Beclomethasone; 3. *Colitis, Ulcerative [drug therapy]; 4. Cyclosporine [therapeutic use]; 5. *Proctitis [drug therapy]; 6. Remission Induction; 7. Suppositories; 8. Tacrolimus [therapeutic use]; | Provide MESH terms for the study
Tacrolimus (FK506) for induction of remission in corticosteroid‐refractory ulcerative colitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Catheterization [adverse effects]; 2. *Cholangiopancreatography, Endoscopic Retrograde [adverse effects, methods]; 3. Common Bile Duct; 4. *Pancreatitis [etiology, prevention & control]; 5. Sphincterotomy, Endoscopic [adverse effects]; | Provide MESH terms for the study
Guidewire‐assisted cannulation of the common bile duct for the prevention of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Endoscopy; 3. Gastrointestinal Hemorrhage [therapy]; 4. *Histamine H2 Antagonists [therapeutic use]; 5. *Proton Pump Inhibitors [therapeutic use]; | Provide MESH terms for the study
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding | You are a research assistant. Based on the question please provide appropriate answers |
1. Anesthesia, Local; 2. *Anesthetics, Local; 3. Bupivacaine; 4. *Cholecystectomy, Laparoscopic [adverse effects]; 5. Quality of Life; | Provide MESH terms for the study
Intraperitoneal local anaesthetic instillation versus no intraperitoneal local anaesthetic instillation for laparoscopic cholecystectomy | You are a research assistant. Based on the question please provide appropriate answers |
1. Fibrin Tissue Adhesive; 2. Hernia, Umbilical [surgery]; 3. Hernia, Ventral [*surgery]; 4. Herniorrhaphy [*methods]; 5. Incisional Hernia [*surgery]; 6. Pain, Postoperative [epidemiology]; 7. Recurrence; 8. Secondary Prevention [methods]; 9. *Surgical Mesh; 10. Sutures; 11. Tissue Adhesives; | Provide MESH terms for the study
Mesh fixation techniques in primary ventral or incisional hernia repair | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta-Antagonists [adverse effects, therapeutic use]; 2. Bias; 3. Combined Modality Therapy [methods]; 4. Drug Therapy, Combination; 5. Esophageal and Gastric Varices [*complications]; 6. Gastrointestinal Hemorrhage [etiology, *prevention & control]; 7. Ligation; 8. Liver Cirrhosis [*complications]; 9. Network Meta-Analysis; 10. Nitrates [therapeutic use]; 11. Portacaval Shunt, Surgical; 12. *Primary Prevention; 13. Randomized Controlled Trials as Topic; 14. Sclerotherapy; | Provide MESH terms for the study
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta-2 Receptor Antagonists [therapeutic use]; 2. Bias; 3. Esophageal and Gastric Varices [*complications, mortality]; 4. Gastrointestinal Hemorrhage [etiology, mortality, *prevention & control]; 5. Ligation [adverse effects, methods]; 6. Liver Cirrhosis [*complications]; 7. Liver Transplantation [statistics & numerical data]; 8. *Network Meta-Analysis; 9. Nitrates [therapeutic use]; 10. *Portasystemic Shunt, Transjugular Intrahepatic [statistics & numerical data]; 11. Randomized Controlled Trials as Topic; 12. Sclerotherapy [adverse effects, mortality]; 13. Secondary Prevention [*methods]; | Provide MESH terms for the study
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [adverse effects]; 2. Aminosalicylic Acids [adverse effects]; 3. Bias; 4. Colitis, Ulcerative [drug therapy]; 5. Confidence Intervals; 6. Crohn Disease [drug therapy]; 7. Immunologic Factors [adverse effects]; 8. Infections [*chemically induced, epidemiology]; 9. Inflammatory Bowel Diseases [*drug therapy]; 10. Integrins [antagonists & inhibitors]; 11. Observational Studies as Topic [statistics & numerical data]; 12. Odds Ratio; 13. Postoperative Complications [*chemically induced, epidemiology]; 14. Surgical Wound Dehiscence [chemically induced, epidemiology]; 15. Surgical Wound Infection [chemically induced, epidemiology]; 16. Time Factors; 17. Tumor Necrosis Factor-alpha [antagonists & inhibitors]; | Provide MESH terms for the study
Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Cause of Death; 3. Endoscopy [*methods]; 4. Esophageal and Gastric Varices [prevention & control, *therapy]; 5. Gastrointestinal Hemorrhage [epidemiology, prevention & control, *therapy]; 6. Hepatic Encephalopathy [epidemiology, etiology]; 7. Intention to Treat Analysis; 8. Liver Cirrhosis [*complications]; 9. Portasystemic Shunt, Surgical [adverse effects, *methods]; 10. Portasystemic Shunt, Transjugular Intrahepatic [adverse effects]; 11. Randomized Controlled Trials as Topic; 12. Secondary Prevention; 13. Splenorenal Shunt, Surgical [adverse effects]; | Provide MESH terms for the study
Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Constipation [*prevention & control]; 2. Defecation; 3. Dietary Fiber [adverse effects, *therapeutic use]; 4. Laxatives [adverse effects, *therapeutic use]; 5. Perineum [injuries]; 6. Postpartum Period; 7. Puerperal Disorders [*prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Time Factors; | Provide MESH terms for the study
Interventions for preventing postpartum constipation | You are a research assistant. Based on the question please provide appropriate answers |
1. Adalimumab [adverse effects, *therapeutic use]; 2. Anti-Inflammatory Agents [adverse effects, *therapeutic use]; 3. Azathioprine [therapeutic use]; 4. Crohn Disease [*drug therapy]; 5. Drug Administration Schedule; 6. Immunosuppressive Agents [therapeutic use]; 7. Maintenance Chemotherapy [*methods, statistics & numerical data]; 8. Mercaptopurine [therapeutic use]; 9. Mesalamine [therapeutic use]; 10. Patient Dropouts [statistics & numerical data]; 11. Placebos [therapeutic use]; 12. Randomized Controlled Trials as Topic; 13. Time Factors; 14. Treatment Outcome; 15. Tumor Necrosis Factor-alpha [antagonists & inhibitors]; | Provide MESH terms for the study
Adalimumab for maintenance of remission in Crohn's disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Antibiotic Prophylaxis; 2. Elective Surgical Procedures [adverse effects, methods]; 3. Hernia, Femoral [*surgery]; 4. Hernia, Inguinal [*surgery]; 5. Herniorrhaphy [*adverse effects, methods]; 6. Randomized Controlled Trials as Topic; 7. Surgical Mesh; 8. Surgical Wound Infection [*prevention & control]; | Provide MESH terms for the study
Antibiotic prophylaxis for prevention of postoperative wound infection in adults undergoing open elective inguinal or femoral hernia repair | You are a research assistant. Based on the question please provide appropriate answers |
1. *Intubation, Gastrointestinal [mortality]; 2. Enteral Nutrition [*methods]; 3. Length of Stay; 4. Nutritional Status; 5. Pancreatitis [mortality, *therapy]; 6. Parenteral Nutrition; 7. Randomized Controlled Trials as Topic; 8. Treatment Outcome; | Provide MESH terms for the study
Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal, Humanized [*therapeutic use]; 2. Crohn Disease [*therapy]; 3. Interleukin‐12 [*antagonists & inhibitors, immunology]; 4. Interleukin‐23 [*antagonists & inhibitors, immunology]; 5. Randomized Controlled Trials as Topic; 6. Remission Induction [methods]; 7. Ustekinumab [therapeutic use]; | Provide MESH terms for the study
Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Adalimumab [*therapeutic use]; 2. Antibodies, Monoclonal, Humanized [*therapeutic use]; 3. Crohn Disease [*therapy]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Remission Induction; 7. Treatment Outcome; | Provide MESH terms for the study
Adalimumab for induction of remission in Crohn's disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta-Antagonists [therapeutic use]; 2. Antifibrinolytic Agents [therapeutic use]; 3. End Stage Liver Disease [complications]; 4. Esophageal and Gastric Varices [*complications, drug therapy, surgery]; 5. Gastrointestinal Hemorrhage [etiology, *prevention & control, *surgery]; 6. Ligation [*methods]; 7. Portal Vein; 8. Primary Prevention; 9. Randomized Controlled Trials as Topic; 10. Venous Thrombosis [complications]; | Provide MESH terms for the study
Band ligation versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal, Humanized [*therapeutic use]; 2. Certolizumab Pegol [*therapeutic use]; 3. Crohn Disease [*drug therapy]; 4. Immunologic Factors [therapeutic use]; 5. Induction Chemotherapy; 6. Randomized Controlled Trials as Topic; 7. Remission Induction; | Provide MESH terms for the study
Certolizumab pegol for induction of remission in Crohn's disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Ascites [etiology, therapy]; 2. *Liver Cirrhosis [complications]; 3. *Paracentesis; 4. *Plasma Substitutes [therapeutic use]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anastomosis, Surgical; 2. Colostomy [adverse effects, methods]; 3. Hernia, Ventral [*etiology, *prevention & control]; 4. Ileostomy [adverse effects, methods]; 5. Prolapse; 6. Randomized Controlled Trials as Topic; 7. Rectum [*surgery]; 8. Rectus Abdominis; 9. Surgical Stomas [*adverse effects]; | Provide MESH terms for the study
Lateral pararectal versus transrectal stoma placement for prevention of parastomal herniation | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [*therapeutic use]; 2. Anxiety [drug therapy]; 3. Case-Control Studies; 4. Depression [*drug therapy]; 5. Inflammatory Bowel Diseases [*psychology]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Glucocorticoids [adverse effects, *therapeutic use]; 2. Hepatitis, Alcoholic [*drug therapy, mortality]; 3. Quality of Life; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Glucocorticosteroids for people with alcoholic hepatitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Helicobacter pylori; 2. Acetylcysteine [adverse effects, *therapeutic use]; 3. Anti‐Bacterial Agents [*therapeutic use]; 4. Chemotherapy, Adjuvant [adverse effects, methods]; 5. Helicobacter Infections [*drug therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [adverse effects, *therapeutic use]; 2. Crohn Disease [*drug therapy]; 3. Induction Chemotherapy [*methods]; 4. Maintenance Chemotherapy [*methods]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotics for induction and maintenance of remission in Crohn's disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetylcarnitine [*therapeutic use]; 2. Ammonia [blood]; 3. Chelating Agents [*therapeutic use]; 4. Fatigue [etiology]; 5. Hepatic Encephalopathy [blood, *drug therapy, etiology]; 6. Liver Cirrhosis [complications]; 7. Mental Fatigue [etiology]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Acetyl‐L‐carnitine for patients with hepatic encephalopathy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Phytotherapy [adverse effects]; 2. Cannabidiol [adverse effects, *therapeutic use]; 3. Capsules; 4. Colitis, Ulcerative [*drug therapy]; 5. Dronabinol [adverse effects, *therapeutic use]; 6. Marijuana Smoking; 7. Medical Marijuana [adverse effects, *therapeutic use]; 8. Patient Dropouts [statistics & numerical data]; 9. Placebos [therapeutic use]; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; 12. Remission Induction; | Provide MESH terms for the study
Cannabis for the treatment of ulcerative colitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Portasystemic Shunt, Surgical [adverse effects, mortality]; 2. *Portasystemic Shunt, Transjugular Intrahepatic [adverse effects, mortality]; 3. Cause of Death; 4. Esophageal and Gastric Varices [complications, mortality, *surgery]; 5. Gastrointestinal Hemorrhage [etiology, mortality, *surgery]; 6. Hepatic Encephalopathy [epidemiology]; 7. Liver Cirrhosis [*complications, mortality]; 8. Randomized Controlled Trials as Topic; 9. Recurrence; 10. Reoperation [statistics & numerical data]; 11. Time Factors; | Provide MESH terms for the study
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Stroke Rehabilitation; 2. Acupuncture Therapy [statistics & numerical data]; 3. Acute Disease; 4. Deglutition; 5. Deglutition Disorders [*etiology, mortality, *rehabilitation]; 6. Electric Stimulation Therapy [statistics & numerical data]; 7. Gastrostomy; 8. Intubation, Gastrointestinal; 9. Length of Stay [statistics & numerical data]; 10. Lisinopril [therapeutic use]; 11. Metoclopramide [therapeutic use]; 12. Nifedipine [therapeutic use]; 13. Physical Stimulation [methods]; 14. Pneumonia [epidemiology]; 15. Randomized Controlled Trials as Topic; 16. Stroke [*complications, mortality]; 17. Time Factors; 18. Transcranial Direct Current Stimulation [statistics & numerical data]; | Provide MESH terms for the study
Swallowing therapy for dysphagia in acute and subacute stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐Antagonists [adverse effects, *therapeutic use]; 2. Carvedilol [adverse effects, *therapeutic use]; 3. Esophageal and Gastric Varices [complications, *drug therapy, mortality]; 4. Gastrointestinal Hemorrhage [mortality, *prevention & control]; 5. Liver Cirrhosis [complications, *drug therapy, mortality]; 6. Nadolol [adverse effects, *therapeutic use]; 7. Primary Prevention; 8. Propranolol [adverse effects, *therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Secondary Prevention; | Provide MESH terms for the study
Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.